Chronic Lymphocytic Leukaemia Presenting with Pancytopenia: A Rare Haematological Coincidence

被引:0
|
作者
Jamal, Iffat [1 ]
Smita, Shuchi [1 ]
Raman, Ravi Bhushan [1 ]
Kumar, Kaushal [1 ]
Choudhary, Vijayanand [1 ]
机构
[1] Indira Gandhi Inst Med Sci, Dept Hematol Pathol, Patna, Bihar, India
关键词
Autoimmune; Cytopenias; Evans syndrome; Lymphocyte count; AUTOIMMUNE HEMOLYTIC-ANEMIA; FLUDARABINE; RITUXIMAB; CYCLOPHOSPHAMIDE; EXPRESSION; SURVIVAL;
D O I
10.7860/JCDR/2021/46541.14858
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic Lymphocytic Leukaemia ( CLL) is commonly associated with autoimmune cytopenias but CLL presenting with pancytopenia is a rare occurrence. Here, we present a case of 56-year- old male patient, who presented with pallor, mild hepatosplenomegaly, right-sided pleural effusion in chest x-ray, pancytopenia and his bone marrow showed infiltration by mature appearing lymphoid cells making a diagnosis of CLL. Despite the frequency of these immune mediated cytopenia, only few cases of pancytopenia have been described so far to the best of our knowledge. Hence, to emphasise the rarity of such haematological coincidence we are presenting this case report. CLL generally presents with persistent absolute lymphocytosis on peripheral smear with an absolute monoclonal lymphocyte count of more than 5000/cumm. There is a common association with Autoimmune Haemolytic Anaemia (AIHA) and Immune Thrombocytopenia (ITP) and the association is called as Evan's syndrome. Its pathogenesis is associated with autoimmune process. AIHA, ITP, and Pure Red Cell Aplasia (PRCA) are commonly associated complications seen in CLL. The pathogenesis of AIHA and ITP are antibody this inplace of the reactions and abnormal T cell activity is noted in the pathogenesis of PRCA. Despite of the frequency of these immune mediated cytopenias noted in CLL, bone marrow was seen to be hypercellular in most of the cases and marrow hypoplasia have been reported in only 2 cases reported in literature so far. In the present case, although pancytopenia was present on peripheral blood smear examination but bone marrow was hypercellular for age with diffuse infiltration by monoclonal mature appearing lymphoid cells which makes this case all the more interesting. Despite repeated blood transfusions,antiviral drug Tenofovir and aggressive supportive measures for 6 months, he developed right-sided pleural effusion and succumbed to his illness.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Autoimmune pancytopenia following combination chemotherapy for chronic lymphocytic leukaemia
    MacCallum, S.
    Groves, M.
    Brass, D.
    Cunningham, J.
    Sales, M.
    Gelly, K.
    Tauro, S.
    JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (05) : 468 - 470
  • [2] Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With Pancytopenia and Chylothorax
    Thomas, Lisa C.
    Maida, Matthew J.
    Martinez-Outschoorn, Ubaldo
    Filicko-O'Hara, Joanne
    Morris, Gloria J.
    SEMINARS IN ONCOLOGY, 2011, 38 (02) : 165 - 170
  • [3] Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice
    Doubek, Michael
    Mayer, Jiri
    Obrtlikova, Petra
    Smolej, Lukas
    Cmunt, Eduard
    Schwarz, Jiri
    Brejcha, Martin
    Kozmon, Petr
    Pospisilova, Sarka
    Brychtova, Yvona
    Pospisil, Zdenek
    Trneny, Marek
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (02) : 130 - 137
  • [4] Current Diagnosis and Treatment of Chronic Lymphocytic Leukaemia
    Cramer, Paula
    von Tresckow, Julia
    Eichhorst, Barbara
    Hallek, Michael
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (16) : 1139 - 1144
  • [5] Rituximab in combination with chemotherapy for the treatment of chronic lymphocytic leukaemia in clinical practice
    Reiser, Marcel
    Doerfel, Steffen
    Hensel, Manfred
    Hoesl, Mark
    Jordan, Wolf-Oliver
    Koenigsmann, Michael
    Meyer, Dirk
    Reichert, Dietmar
    Schwarzer, Andreas
    Marquardt, Moritz
    Kellershohn, Kerstin
    Jentsch-Ullrich, Kathleen
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (05) : 455 - 464
  • [6] Management of patients with previously untreated chronic lymphocytic leukaemia with obinutuzumab and chlorambucil
    Tam, Constantine
    Kuss, Bryone
    Opat, Stephen
    Boulos, Joy
    Marlton, Paula
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 5 - 10
  • [7] Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome
    Shen, Yandong
    Coyle, Luke
    Kerridge, Ian
    Stevenson, William
    Arthur, Christopher
    McKinlay, Naomi
    Fay, Keith
    Ward, Christopher
    Greenwood, Matthew
    Best, Oliver Giles
    Solterbeck, Ann
    Guminski, Alexander
    Shumack, Stephen
    Mulligan, Stephen P.
    EJHAEM, 2022, 3 (01): : 129 - 138
  • [8] Early clinical trials in chronic lymphocytic leukaemia in the UK
    Catovsky, Daniel
    Else, Monica
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (04) : 535 - 541
  • [9] Prediction of chronic lymphocytic leukaemia incidence in Germany and of patients ineligible for standard chemotherapy
    Eisemann, Nora
    Schnoor, Maike
    Katalinic, Alexander
    HEMATOLOGICAL ONCOLOGY, 2016, 34 (02) : 93 - 101
  • [10] Chronic lymphocytic leukaemia Australasian consensus practice statement
    Anderson, Mary A.
    Bennett, Rory
    Badoux, Xavier
    Best, Giles
    Chia, Nicole
    Cochrane, Tara
    Cull, Gavin
    Crassini, Kyle
    Harrup, Rosemary
    Jackson, Sharon
    Kuss, Bryone
    Lasica, Masa
    Lew, Thomas E.
    Marlton, Paula
    Opat, Stephen
    Palfreyman, Emma
    Polizzotto, Mark N.
    Ratnasingam, Sumita
    Seymour, John F.
    Soosapilla, Asha
    Talaulikar, Dipti
    Tam, Constantine S.
    Weinkove, Robert
    Wight, Joel
    Mulligan, Stephen P.
    INTERNAL MEDICINE JOURNAL, 2023, 53 (09) : 1678 - 1691